Search

Your search keyword '"ANTIGENIC shift"' showing total 801 results

Search Constraints

Start Over You searched for: Descriptor "ANTIGENIC shift" Remove constraint Descriptor: "ANTIGENIC shift" Language undetermined Remove constraint Language: undetermined
801 results on '"ANTIGENIC shift"'

Search Results

1. Influenza viruses

2. Foot and mouth disease virus: A review

3. Influenza and Influenza Vaccine: A Review

4. Emergence and evolution of novel G2b-like porcine epidemic diarrhea virus inter-subgroup G1b recombinants

5. Broadly Reactive IgG Responses to Heterologous H5 Prime-Boost Influenza Vaccination Are Shaped by Antigenic Relatedness to Priming Strains

6. Intragastric delivery of recombinant Lactococcus lactis displaying ectodomain of influenza matrix protein 2 (M2e) and neuraminidase (NA) induced focused mucosal and systemic immune responses in chickens

7. H5N8 and H7N9 packaging signals constrain HA reassortment with a seasonal H3N2 influenza A virus

8. Efficacy of recombinant NP-M1 and NP-M1-CRT DNA vaccines against Influenza A viruses in mice C57/BL6

9. Broadly-reactive IgG responses to heterologous H5 prime-boost influenza vaccination are shaped by antigenic relatedness to priming strains

10. Antiviral effect of a nucleic acid hydrolyzing scFv against oseltamivir resistant influenza A virus

11. A Mathematical Modeling Study: Assessing Impact of Mismatch Between Influenza Vaccine Strains and Circulating Strains in Hajj

12. Antigenic shift during Trichinella cycle, consequences for vaccine developments

13. Hemagglutinin Stalk-based Monoclonal Antibody Elicits Broadly Reactivity Against Group 1 Influenza A Virus

14. A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

15. Pandemic Influenza A Virus (pH1N1)

16. Guava flavonoid glycosides prevent influenza A virus infection via rescue of P53 activity

17. Clinical and molecular epidemiology of influenza viruses from Romanian patients hospitalized during the 2019/20 season

18. Novel insights into bat influenza A viruses

19. Selection of antigenic variants of an H5N1 highly pathogenic avian influenza virus in vaccinated chickens

20. Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses

21. In vitro and in vivo evidence of a potential A(H1N1)pdm09 antigenic drift mediated by escape mutations in the haemagglutinin Sa antigenic site

22. Molecular analysis of amantadine-resistant influenza A (H1N1 pdm09) virus isolated from slum dwellers of Dhaka, Bangladesh

23. Detection of Antigenic Variants of Subtype H3 Swine Influenza A Viruses from Clinical Samples

24. Antigenic and genetic characterization of influenza viruses circulating in Bulgaria during the 2015/2016 season

25. Pathogenicity of modified bat influenza virus with different M genes and its reassortment potential with swine influenza A virus

26. The PB2-K627E mutation attenuates H3N2 swine influenza virus in cultured cells and in mice

27. Development of an adjuvanted nanoparticle vaccine against influenza virus, an in vitro study

28. Identification of cellular microRNA miR-188-3p with broad-spectrum anti-influenza A virus activity

29. Development of Universal Influenza Vaccines Targeting Conserved Viral Proteins

30. Overview of Current Therapeutics and Novel Candidates Against Influenza, Respiratory Syncytial Virus, and Middle East Respiratory Syndrome Coronavirus Infections

31. Current and Novel Approaches in Influenza Management

32. Avian Influenza in Wild Birds and Poultry: Dissemination Pathways, Monitoring Methods, and Virus Ecology

33. Mechanisms of replacement of circulating viruses by seasonal and pandemic influenza A viruses

34. Antigenic characterization of influenza viruses produced using synthetic DNA and novel backbones

35. Genetic and antigenic characterization of hemagglutinin of influenza A/H3N2 virus from the 2015 season in Thailand

36. VARIABILITY OF THE INFLUENZA A VIRUS

37. The C-Terminal Tail of TRIM56 Dictates Antiviral Restriction of Influenza A and B Viruses by Impeding Viral RNA Synthesis

38. Un modelo didáctico para comprender la estructura y mecanismos de acción de los virus y su relación con el desarrollo de nuevas vacunas

39. Back to the Future for Influenza Preimmunity-Looking Back at Influenza Virus History to Infer the Outcome of Future Infections

40. Influenza Virus: Dealing with a Drifting and Shifting Pathogen

41. Alignment-Free Analyses of Nucleic Acid Sequences Using Graphical Representation (with Special Reference to Pandemic Bird Flu and Swine Flu)

42. Novel reassortant influenza viruses between pandemic (H1N1) 2009 and other influenza viruses pose a risk to public health

43. Antiviral Drugs Targeting Influenza Virus Surface Proteins: A Computational Structural Biology Approach

44. Small RNAs targeting the 5′ end of the viral polymerase gene segments specifically interfere with influenza type A virus replication

45. Competition, coinfection and strain replacement in models of Bordetella pertussis

46. Risk factors for poor outcomes and therapeutic strategies for seasonal and pandemic influenza

47. Antigenic variation of the human influenza A (H3N2) virus during the 2014–2015 winter season

48. Using epidemics to map H3 equine influenza virus determinants of antigenicity

49. Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014–2015 Influenza Season

50. Molecular characterization of H9N2 avian influenza viruses isolated from vaccinated broiler chickens in northeast Iran

Catalog

Books, media, physical & digital resources